Gut microbiota analysis revealed that Cb-GLP-1 restored gut homeostasis disrupted in T2DM mice, as indicated by the decreased abundance of <i>Lactobacillus</i> and <i>Providencia</i> genera in response to Cb-GLP-1 treatment. Here, GLP1R is linked to type 2 diabetes mellitus.